Something unusual is happening to biotech stocks: They’re going up. A drug-pricing deal between Pfizer and the White House and a spate of deals have sent the SPDR S&P Biotech exchange-traded fund up 9 ...
In September 2024, Akeso, a little-known Chinese biopharmaceutical company, announced that clinical trials had shown that its new drug could halt the progression of a type of lung cancer for nearly a ...
Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...
Nascent cardiovascular biotech Kardigan is continuing its bumper year with a pulse-quickening $254 million series B fundraising round, bringing the company’s total financing to more than half a ...
Biotech is "at the cusp of a golden age" in the U.S., and Illinois will capitalize on it by taking advantage of the changes on the horizon, like AI and quantum science, said John Crowley, president ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Lisa Stiffler on Oct 10, 2025 at ...
Evommune, which is developing drugs targeting the sources of chronic inflammatory diseases, filed for an initial public offering. The Palo Alto, Calif., company is seeking a New York Stock Exchange ...
Federal funding cuts and threats to higher education are putting key ingredients of Boston’s recipe for biotech success in jeopardy For more than a decade, Boston has been the undisputed capital of ...
The U.S. is falling behind in biotechnology development, Sen. Todd Young, R-Ind., said Wednesday—adding that he and other lawmakers are working to help the country catch up with China’s push to ...
Mary Brunkow speaks at an event Tuesday at Seattle’s Institute for Systems Biology celebrating her 2025 Nobel Prize in Physiology or Medicine. (ISB Photo / Alex Garland) The groundbreaking immunology ...
Benzinga’s Edge Stock Rankings system scores stocks across key measures including momentum, growth, value and quality. The momentum score serves as a key indicator for traders looking to capitalize on ...
In this article, we will look at the top 14 Biotech Stocks with High Potential. On October 1, Evan Seigerman, head of healthcare research at BMO Capital Markets, appeared on CNBC’s “The Exchange” to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback